Getting weight-loss treatment from an online pharmacy in the UK is legal, safe and increasingly common — but only when the pharmacy is properly regulated and a prescriber has assessed you first. The medicines involved (Mounjaro, Wegovy and similar GLP-1 treatments) are prescription-only. That means no legitimate service can, or should, sell them to you without a clinical assessment, no matter how slick the checkout looks.
This guide explains how regulated online care actually works: what "regulated" means in practice, how the consultation and prescriber review protect you, who is eligible, how the main medicines compare, and how to tell a genuine pharmacy from a risky one. It's written to answer the questions people actually type into a search bar — including whether you need to see your GP first, and whether a video call is now required.
Can you get weight-loss medication online without seeing a GP?
Yes — you do not need a GP referral to be treated by a regulated online pharmacy. That's one of the reasons remote care has grown so fast: NHS specialist weight-management services are stretched, and eligibility for NHS-funded medication is narrow, so many people who qualify under the medicine's licence still can't access it on the NHS.
But "no GP referral" is not the same as "no medical oversight." Since 4 February 2025, the General Pharmaceutical Council (GPhC) has required online pharmacies supplying weight-management medicines to independently verify a person's weight, height and/or BMI before prescribing — a questionnaire answer alone is not enough — and to keep a means of two-way communication with the patient. (General Pharmaceutical Council)
In plain terms: a real online pharmacy still has to do the safety work a good clinic would do in person. It just does it remotely. You'll always be assessed by a UK-registered prescriber before anything is dispensed, and it's sensible to tell your own GP you've started treatment so your records stay joined up.
Is a video consultation now required?
Not always a video call specifically — but the days of a tick-box form with no verification are over. The 2025 GPhC guidance says prescribers can't rely on an online questionnaire alone for higher-risk medicines like GLP-1s. They must independently confirm the key clinical facts through a route such as two-way conversation with the patient, checking clinical records, or contacting the GP or previous prescriber. (General Pharmaceutical Council)
Some providers meet this with a video or photo-based identity and measurement check; others verify against records. The point isn't the exact method — it's that a person genuinely eligible for treatment is the person being treated, at the weight they say they are. If a website skips this entirely, that's a red flag, not a convenience.
What does "regulated" actually mean here?
Three separate safeguards sit behind a legitimate service, and it's worth knowing all three:
- A GPhC-registered pharmacy. The pharmacy premises are registered with, and inspected by, the General Pharmaceutical Council — the statutory regulator for pharmacies in Great Britain.
- A named, accountable prescriber. A UK-registered pharmacist independent prescriber (or doctor) is personally responsible for the decision to prescribe, and is answerable to their professional regulator for it.
- A licensed medicine, supplied appropriately. The product is an MHRA-licensed medicine dispensed against a valid prescription — not an unlicensed or grey-market "pen."
The Medicines and Healthcare products Regulatory Agency (MHRA) has repeatedly warned that buying weight-loss injections from social media sellers or unregulated sites risks receiving counterfeit or contaminated products that have never been checked for safety, quality or effectiveness. (MHRA / GOV.UK)
How to check a pharmacy in two minutes
- Look for the green GPhC "Registered Pharmacy" logo, usually in the site footer. It should carry a registration number and link through to the register.
- Go to the GPhC register and search the pharmacy's name or number to confirm it's currently registered.
- Check that a superintendent pharmacist and a UK address are named. A clinic operating outside UK jurisdiction isn't bound by these standards, and you'd have little recourse if something went wrong.
The Weight Clinic is a GPhC-registered UK pharmacy. Prescribing is overseen by named clinicians — Superintendent Pharmacist Andrew Lane and Pharmacist Independent Prescriber Fatma Al Sibahi — so there's an accountable professional behind every decision, not an anonymous app.
Which medicine: Mounjaro, Wegovy or the new oral options?
There isn't a single "best" treatment — the right one depends on your health history, what you tolerate, and a prescriber's judgement. Here's an honest comparison of the main options, with every efficacy figure tied to its named trial. Results in trials are averages, and individual results vary.
| Treatment | Active drug | How it's given | How it works | Trial-based average weight loss |
|---|---|---|---|---|
| Mounjaro | Tirzepatide | Weekly injection | Dual-action: mimics GLP-1 and GIP hormones | ~22.5% of body weight at the 15 mg dose over 72 weeks (SURMOUNT-1) |
| Wegovy | Semaglutide | Weekly injection | Single-action: mimics GLP-1 | ~14.9% of body weight at the 2.4 mg dose over 68 weeks (STEP-1) |
| Foundayo / orforglipron | Orforglipron | Daily tablet | Oral GLP-1 (small molecule) | ~11–12% at the highest dose over ~72 weeks (Phase 3 ATTAIN programme) |
The tirzepatide figure of about 22.5% comes from the SURMOUNT-1 trial at the 15 mg dose over 72 weeks. (New England Journal of Medicine) The semaglutide figure of about 14.9% comes from STEP-1 at the 2.4 mg dose over 68 weeks. (New England Journal of Medicine)
Mounjaro tends to produce larger average loss because it targets two hormone pathways rather than one. Wegovy has a longer real-world track record and cardiovascular-outcome data behind it, which some prescribers weigh when choosing a starting point. If you'd like the detail, our dedicated pages on Mounjaro and Wegovy go deeper on each.
Oral options. An oral GLP-1, orforglipron, was approved by the US FDA under the brand name Foundayo on 1 April 2026, and authorised in the UK by the MHRA on 10 August 2026. A marketing authorisation permits a medicine to be prescribed here; it does not mean any particular pharmacy stocks it. We do not supply it yet, and intend to once we are able to obtain it. (BHF Heart Matters) We cover where that leaves needle-free treatment today on our Wegovy Tablet page. You can see the full range of what we can prescribe now on our treatments page or the weight-loss injections overview.
Who is eligible?
Under the UK licence for these medicines, treatment is generally appropriate for adults with a BMI of 30 or above, or a BMI of 27 or above with a weight-related health condition such as type 2 diabetes, high blood pressure or obstructive sleep apnoea.
A prescriber also has to rule out reasons the medicine wouldn't be safe for you. GLP-1 treatments are not suitable in pregnancy or while breastfeeding, and a personal or family history of medullary thyroid carcinoma, or the condition MEN 2, is a firm contraindication. A history of pancreatitis, gallbladder disease or certain other conditions calls for careful clinical judgement.
Being told no is a sign the system is working, not a failure of the service. A regulated provider that declines an unsafe or inappropriate request is doing exactly what it should.
Safety: the balanced picture
Most side effects are gastrointestinal and appear as your body adjusts: nausea, reflux, constipation or diarrhoea. They're usually most noticeable early on and often ease with time. This is why dosing starts low and increases slowly — for Mounjaro, treatment begins at 2.5 mg and steps up by 2.5 mg no sooner than every four weeks, to a maximum of 15 mg, so your body has time to adapt at each stage.
The rarer but more serious risks matter too, and a good prescriber will make sure you know them. These include acute pancreatitis (severe, persistent abdominal pain, sometimes with vomiting) and gallbladder problems such as gallstones. Rapid weight loss itself can raise gallstone risk. If you develop severe or persistent abdominal pain, seek medical help promptly rather than waiting.
If you experience a side effect you suspect is linked to a medicine, you — or your pharmacist — can and should report it through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. Reports feed directly into ongoing safety monitoring. And you should never change your dose or stop treatment on a hunch — check with your prescriber first, because how these medicines are started and stepped up is part of what keeps them safe.
None of this is a reason to be frightened off treatment; it's the reason treatment belongs with a prescriber who knows your history rather than an anonymous checkout. The point of the assessment, the slow titration and the ongoing check-ins is to catch the rare problems early and keep the common ones manageable.
How it works at The Weight Clinic
The process is deliberately clinical, and deliberately simple to start:
- Free eligibility check. You answer a structured medical questionnaire covering your BMI, health conditions and current medicines. There's no charge to find out whether treatment is suitable, and no subscription.
- Prescriber review. A UK-registered independent prescriber reviews your answers and verifies the key details, in line with GPhC guidance, before any decision is made. If treatment isn't right for you, we'll tell you why.
- Dispensing and delivery. If you're suitable, your prescription is dispensed by our registered pharmacy and sent in plain, unbranded packaging. GLP-1 injections are temperature-sensitive and are handled accordingly.
- Ongoing care. Reordering isn't automatic — it's a check-in on how you're getting on and whether your dose should change, with clinicians you can actually ask questions.
On price, there's no lock-in: Mounjaro from £125 a month, and Wegovy from £80 for your first month (standard £115, with £35 off your first order using code NEWME).
If you want to know whether this is a safe and appropriate route for you, the honest first step is to check your eligibility — it's free and takes a few minutes.
Frequently asked questions
Medication is one part of long-term weight management; sustained change comes from combining it with diet, activity and support. Treat what follows as general information, not personal medical advice — a prescriber's assessment always comes first.
Frequently asked questions
Can I buy Mounjaro or Wegovy online without a prescription?
No. Mounjaro and Wegovy are prescription-only medicines, and no legitimate UK pharmacy can supply them without a clinical assessment. A UK-registered prescriber must review your health information and agree treatment is suitable before anything is dispensed. Any site offering to sell them with no consultation is operating unlawfully and unsafely — the MHRA warns these sources risk counterfeit or contaminated products.
Do I need to see my GP before starting?
You don't need a GP referral to be treated by a regulated online pharmacy. However, you will still be assessed by a UK-registered prescriber, and since February 2025 that prescriber must independently verify your weight, height and BMI rather than relying on a questionnaire alone. It's sensible to tell your own GP you've started treatment so your medical records stay joined up.
Am I eligible for weight-loss medication?
Under the UK licence, treatment is generally appropriate for adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related condition such as type 2 diabetes, high blood pressure or obstructive sleep apnoea. A prescriber also checks for reasons it wouldn't be safe — for example pregnancy or breastfeeding, or a personal or family history of medullary thyroid carcinoma or MEN 2. The free eligibility check is the quickest way to find out.
How much does treatment cost at The Weight Clinic?
Mounjaro starts from £125 a month and Wegovy from £80 for your first month (standard £115, with £35 off your first order using code NEWME). The eligibility check is free and there's no subscription or lock-in — reordering is a clinical check-in, not an automatic charge.
What are the side effects, and how do I report one?
The most common side effects are gastrointestinal — nausea, reflux, constipation or diarrhoea — and usually ease as your body adjusts, which is why the dose is started low and increased slowly. Rarer but more serious risks include acute pancreatitis and gallbladder problems. If you experience a suspected side effect, you or your pharmacist can report it to the MHRA through the Yellow Card scheme at yellowcard.mhra.gov.uk, and you should always speak to your prescriber before changing or stopping treatment.
